GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gala Pharmaceutical Inc (OTCPK:GLPH) » Definitions » Enterprise Value

Gala Pharmaceutical (Gala Pharmaceutical) Enterprise Value : $0.11 Mil (As of May. 06, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Gala Pharmaceutical Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Gala Pharmaceutical's Enterprise Value is $0.11 Mil. Gala Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in May. 2019 was $-3.53 Mil. Therefore, Gala Pharmaceutical's EV-to-EBIT ratio for today is -0.03.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Gala Pharmaceutical's Enterprise Value is $0.11 Mil. Gala Pharmaceutical's EBITDA for the trailing twelve months (TTM) ended in May. 2019 was $-3.51 Mil. Therefore, Gala Pharmaceutical's EV-to-EBITDA ratio for today is -0.03.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Gala Pharmaceutical's Enterprise Value is $0.11 Mil. Gala Pharmaceutical's Revenue for the trailing twelve months (TTM) ended in May. 2019 was $0.00 Mil. Therefore, Gala Pharmaceutical's EV-to-Revenue ratio for today is .


Gala Pharmaceutical Enterprise Value Historical Data

The historical data trend for Gala Pharmaceutical's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gala Pharmaceutical Enterprise Value Chart

Gala Pharmaceutical Annual Data
Trend Nov11 Nov12 Nov13 Nov14 Nov15 Nov16 Nov17 Nov18
Enterprise Value
Get a 7-Day Free Trial 7.28 2.27 1.21 8.26 3.77

Gala Pharmaceutical Quarterly Data
Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.51 6.10 3.77 1.91 3.40

Competitive Comparison of Gala Pharmaceutical's Enterprise Value

For the Biotechnology subindustry, Gala Pharmaceutical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gala Pharmaceutical's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gala Pharmaceutical's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Gala Pharmaceutical's Enterprise Value falls into.



Gala Pharmaceutical Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Gala Pharmaceutical's Enterprise Value for the fiscal year that ended in Nov. 2018 is calculated as

Gala Pharmaceutical's Enterprise Value for the quarter that ended in May. 2019 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gala Pharmaceutical  (OTCPK:GLPH) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Gala Pharmaceutical's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.106/-3.529
=-0.03

Gala Pharmaceutical's current Enterprise Value is $0.11 Mil.
Gala Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in May. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.53 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Gala Pharmaceutical's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=0.106/-3.511
=-0.03

Gala Pharmaceutical's current Enterprise Value is $0.11 Mil.
Gala Pharmaceutical's EBITDA for the trailing twelve months (TTM) ended in May. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.51 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Gala Pharmaceutical's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.106/0
=

Gala Pharmaceutical's current Enterprise Value is $0.11 Mil.
Gala Pharmaceutical's Revenue for the trailing twelve months (TTM) ended in May. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gala Pharmaceutical Enterprise Value Related Terms

Thank you for viewing the detailed overview of Gala Pharmaceutical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Gala Pharmaceutical (Gala Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
18881 Von Karman Avenue, Suite 1440, Irvine, CA, USA, 92612
Gala Pharmaceutical Inc is a United States-based company engaged in the hemp and cannabidiol (CBD) industry. It is focused on the development, research, and commercialization of products derived from the hemp and cannabis plant. It is focused on CBD flavored thin-film strip which is an advanced method of providing CBD for the dietary supplement. The services offered by the company are the development of cannabinoid-based health and wellness products; development of medical grade compounds; licensing of proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal herb industry. The group earns revenue from the sale of products related to hemp and CBD, including modified electronic cigarettes and vape pens.